109 related articles for article (PubMed ID: 38854453)
1. Serum Levels of N- and C-ERC/Mesothelin and Clinicopathological Factors in Mesothelioma Patients and Those without Mesothelioma.
Koyanagi AI; Kajino K; Nojiri S; Abe M; Kobayashi T; Sugitani Y; Yue L; Ohtsuji N; Arakawa A; Sato T; Takahashi K; Suzuki K; Orimo A; Yao T; Hino O
Juntendo Iji Zasshi; 2023; 69(2):124-136. PubMed ID: 38854453
[TBL] [Abstract][Full Text] [Related]
2. Novel ELISA system for detection of N-ERC/mesothelin in the sera of mesothelioma patients.
Shiomi K; Miyamoto H; Segawa T; Hagiwara Y; Ota A; Maeda M; Takahashi K; Masuda K; Sakao Y; Hino O
Cancer Sci; 2006 Sep; 97(9):928-32. PubMed ID: 16776777
[TBL] [Abstract][Full Text] [Related]
3. Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma.
Inami K; Kajino K; Abe M; Hagiwara Y; Maeda M; Suyama M; Watanabe S; Hino O
Oncol Rep; 2008 Dec; 20(6):1375-80. PubMed ID: 19020717
[TBL] [Abstract][Full Text] [Related]
4. Serum level of expressed in renal carcinoma (ERC)/ mesothelin in rats with mesothelial proliferative lesions induced by multi-wall carbon nanotube (MWCNT).
Sakamoto Y; Dai N; Hagiwara Y; Satoh K; Ohashi N; Fukamachi K; Tsuda H; Hirose A; Nishimura T; Hino O; Ogata A
J Toxicol Sci; 2010 Apr; 35(2):265-70. PubMed ID: 20371980
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a novel specific ELISA system for rat N- and C-ERC/mesothelin. Rat ERC/mesothelin in the body fluids of mice bearing mesothelioma.
Hagiwara Y; Hamada Y; Kuwahara M; Maeda M; Segawa T; Ishikawa K; Hino O
Cancer Sci; 2008 Apr; 99(4):666-70. PubMed ID: 18294289
[TBL] [Abstract][Full Text] [Related]
6. ERC/mesothelin is expressed in human gastric cancer tissues and cell lines.
Ito T; Kajino K; Abe M; Sato K; Maekawa H; Sakurada M; Orita H; Wada R; Kajiyama Y; Hino O
Oncol Rep; 2014 Jan; 31(1):27-33. PubMed ID: 24146039
[TBL] [Abstract][Full Text] [Related]
7. ERC/mesothelin as a marker for chemotherapeutic response in patients with mesothelioma.
Tajima K; Hirama M; Shiomi K; Ishiwata T; Yoshioka M; Iwase A; Iwakami S; Yamazaki M; Toba M; Tobino K; Sugano K; Ichikawa M; Hagiwara Y; Takahashi K; Hino O
Anticancer Res; 2008; 28(6B):3933-6. PubMed ID: 19192652
[TBL] [Abstract][Full Text] [Related]
8. Possible reversibility between epithelioid and sarcomatoid types of mesothelioma is independent of ERC/mesothelin expression.
Kojima M; Kajino K; Momose S; Wali N; Hlaing MT; Han B; Yue L; Abe M; Fujii T; Ikeda K; Hino O
Respir Res; 2020 Jul; 21(1):187. PubMed ID: 32677949
[TBL] [Abstract][Full Text] [Related]
9. Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma.
Shiomi K; Hagiwara Y; Sonoue K; Segawa T; Miyashita K; Maeda M; Izumi H; Masuda K; Hirabayashi M; Moroboshi T; Yoshiyama T; Ishida A; Natori Y; Inoue A; Kobayashi M; Sakao Y; Miyamoto H; Takahashi K; Hino O
Clin Cancer Res; 2008 Mar; 14(5):1431-7. PubMed ID: 18316566
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of anti-C-ERC/mesothelin monoclonal antibody in vivo.
Inami K; Abe M; Takeda K; Hagiwara Y; Maeda M; Segawa T; Suyama M; Watanabe S; Hino O
Cancer Sci; 2010 Apr; 101(4):969-74. PubMed ID: 20100205
[TBL] [Abstract][Full Text] [Related]
11. Bisecting-GlcNAc on Asn388 is characteristic to ERC/mesothelin expressed on epithelioid mesothelioma cells.
Fujihira H; Takakura D; Matsuda A; Abe M; Miyazaki M; Nakagawa T; Kajino K; Denda-Nagai K; Noji M; Hino O; Irimura T
J Biochem; 2021 Oct; 170(3):317-326. PubMed ID: 33792699
[TBL] [Abstract][Full Text] [Related]
12. MESOMARK kit detects C-ERC/mesothelin, but not SMRP with C-terminus.
Segawa T; Hagiwara Y; Ishikawa K; Aoki N; Maeda M; Shiomi K; Hino O
Biochem Biophys Res Commun; 2008 May; 369(3):915-8. PubMed ID: 18328258
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma.
Mundt F; Nilsonne G; Arslan S; Csürös K; Hillerdal G; Yildirim H; Metintas M; Dobra K; Hjerpe A
PLoS One; 2013; 8(8):e72030. PubMed ID: 23991032
[TBL] [Abstract][Full Text] [Related]
14. The utility of serum N-ERC/mesothelin as a biomarker of ovarian carcinoma.
Saeki H; Hashizume A; Izumi H; Suzuki F; Ishi K; Nojima M; Maeda M; Hino O
Oncol Lett; 2012 Oct; 4(4):637-641. PubMed ID: 23205076
[TBL] [Abstract][Full Text] [Related]
15. Impact of renal failure on the tumor markers of mesothelioma, N-ERC/mesothelin and osteopontin.
Shiomi K; Shiomi S; Ishinaga Y; Sakuraba M; Hagiwara Y; Miyashita K; Maeda M; Suzuki K; Takahashi K; Hino O
Anticancer Res; 2011 Apr; 31(4):1427-30. PubMed ID: 21508397
[TBL] [Abstract][Full Text] [Related]
16. Newly established ELISA for N-ERC/mesothelin improves diagnostic accuracy in patients with suspected pleural mesothelioma.
Sato T; Suzuki Y; Mori T; Maeda M; Abe M; Hino O; Takahashi K
Cancer Med; 2014 Oct; 3(5):1377-84. PubMed ID: 25045139
[TBL] [Abstract][Full Text] [Related]
17. Suppression of cell death by the secretory form of N-terminal ERC/mesothelin.
Wang T; Kajino K; Abe M; Tan K; Maruo M; Sun G; Hagiwara Y; Maeda M; Hino O
Int J Mol Med; 2010 Aug; 26(2):185-91. PubMed ID: 20596597
[TBL] [Abstract][Full Text] [Related]
18. Establishment of the enzyme-linked immunosorbent assay system to detect the amino terminal secretory form of rat Erc/Mesothelin.
Nakaishi M; Kajino K; Ikesue M; Hagiwara Y; Kuwahara M; Mitani H; Horikoshi-Sakuraba Y; Segawa T; Kon S; Maeda M; Wang T; Abe M; Yokoyama M; Hino O
Cancer Sci; 2007 May; 98(5):659-64. PubMed ID: 17425688
[TBL] [Abstract][Full Text] [Related]
19. Development of positron emission tomography imaging by 64Cu-labeled Fab for detecting ERC/mesothelin in a mesothelioma mouse model.
Yoshida C; Sogawa C; Tsuji AB; Sudo H; Sugyo A; Uehara T; Hino O; Yoshii Y; Fujibayashi Y; Fukumura T; Koizumi M; Arano Y; Saga T
Nucl Med Commun; 2010 May; 31(5):380-8. PubMed ID: 20072072
[TBL] [Abstract][Full Text] [Related]
20. Establishment of novel mAb to human ERC/mesothelin useful for study and diagnosis of ERC/mesothelin-expressing cancers.
Ishikawa K; Segawa T; Hagiwara Y; Maeda M; Abe M; Hino O
Pathol Int; 2009 Mar; 59(3):161-6. PubMed ID: 19261093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
